Company patents
Galderma Holding SA
Galderma Holding SA's patent strategy reveals a surprising and strong emphasis on materials science, with Polymer Working & Compounding (29.0% of portfolio) and Polymer Compositions (23.2% of portfolio) being significant areas, alongside its expected focus on Pharmaceutical Preparations (43.5% of portfolio). While Drug Delivery Devices saw a sharp decline in patenting activity with a -100.0% YoY drop so far in 2026, the company is showing an emerging focus in Acyclic / Carbocyclic Compounds and Acyclic / Cyclic Compounds (Other Elements), both experiencing a remarkable +200.0% YoY growth in 2026, indicating a potential shift towards foundational chemical innovation within its pharma_biotech sector.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
69 US filings (since 2023) · 12 categories · 13 themes
Synthesis and application of crosslinked polymer networks designed to swell in water, often for medical, sensing, or smart material applications, exhibiting properties like hydrolysis resistance, thermochromism, or radiation protection.
Polymer compositions tailored for medical and biological applications, including implantable devices, drug delivery systems, and diagnostic tools, emphasizing properties like biocompatibility, hydrolysis resistance, optical clarity, and specific mechanical characteristics.
Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.
Mechanical or electromechanical systems designed for precise, often self-administered, delivery of medicaments, including features for dose setting, needle insertion/retraction, and safety mechanisms to prevent premature activation.
Materials and structures designed for implantation or tissue regeneration, focusing on properties like biodegradability, mechanical strength, cellular integration, and long-term in-vivo stability.
Innovations in creating stable cosmetic formulations, particularly oil-in-water or water-in-oil emulsions, and developing novel stabilizers or rheology modifiers for desired texture, feel, and shelf-life.
Development of small molecules, often bifunctional (e.g., PROTACs) or molecular glues, that induce the ubiquitin-proteasome system or autophagy to selectively degrade specific disease-causing proteins.
Formulations and active ingredients designed to counteract signs of skin aging, such as wrinkles and hyperpigmentation, or to promote skin repair and regeneration through specific biological mechanisms.
Design and engineering of proteins or peptides to directly modulate immune responses, including enhancing antigen presentation, suppressing inflammation, or activating specific immune cell types.
Development and application of polymer compositions designed for reprocessability, recyclability, or incorporating sustainable additives, often featuring reversible bonds or bio-based components.
Compositions specifically developed for maintaining oral hygiene, preventing dental issues like cavities and gingivitis, and improving cosmetic aspects such as teeth whitening.
Development of personal care compositions that achieve effective cleansing and conditioning benefits while avoiding harsh sulfated surfactants, often using alternative, milder surfactant systems.
Processes and methodologies for the efficient and scalable preparation of complex heterocyclic compounds and their precursors, including specific reaction conditions, purification techniques, and intermediate compounds.
Patents
Showing 1-10 of 116